Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study

June 2025 in “ International Journal of Science and Research (IJSR) ”

N Swathi, H C Mangala, x Sugareddy

tofacitinib alopecia areata Severity of Alopecia Areata score SALT score

From the encyclopedia

Tofacitinib →

a JAK inhibitor for alopecia areata and other autoimmune conditions

Alopecia Areata →

autoimmune disorder causing patchy hair loss

Studysummary This study found that oral tofacitinib at a 5mg twice daily dosage was effective in treating recalcitrant alopecia areata, showing significant improvement in hair regrowth and a 27% reduction in SALT scores over six months, with minimal side effects among the 19 patients monitored.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on ijsr.net →

Discuss this study in the Community →

Related Research

7 / 7 results

research Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth

November 2023 in “Cutis”

This case report presented the successful treatment of a patient with alopecia universalis using tofacitinib.

research Trichoscopy in Alopecia Areata

January 2021 in “International journal of dermatology, venereology and leprosy sciences”

This study found that, among 100 patients with alopecia areata, the most prevalent subtype was patchy alopecia areata, with characteristic trichoscopic features including black dots, yellow dots, and empty hair follicles.

research Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib

4 citations , July 2018 in “PubMed”

This study reports significant hair regrowth in 11 patients with severe alopecia areata following longstanding treatment with oral tofacitinib and also highlights successful treatment using topical tofacitinib cream in one case.

research Excellent Response to Tofacitinib Treatment in a Patient with Alopecia Universalis

16 citations , January 2017 in “Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.)”

This case study reports that a 23-year-old woman with alopecia universalis experienced complete hair regrowth after six months of treatment with tofacitinib, a JAK-3 inhibitor.

Review of Representative Trichoscopic Findings in Androgenetic and Alopecia Areata Patients Visiting Dermatology Outpatient Clinic at University Hospital

research Review of Representative Trichoscopic Findings in Androgenetic and Alopecia Areata Patients Visiting Dermatology Outpatient Clinic at University Hospital

November 2016 in “대한피부과학회지”

This study found that trichoscopy is effective for diagnosing androgenetic alopecia and alopecia areata, and it can also be used to assess the severity of androgenetic alopecia.

research Alopecia Areata Universalis in a Dog

5 citations , June 2015 in “Veterinary dermatology”

This case report describes a canine with alopecia areata universalis treated with oral ciclosporin, which was associated with hair regrowth, but some areas remained hairless after 17 months.

research Extensive Alopecia Areata: Not Necessarily Recalcitrant to Therapy

14 citations , January 2011 in “International Journal of Trichology”

This study reports that combination therapy with oral steroids, anthralin, and minoxidil yielded effective cosmetic responses in 80% of patients with treatment-resistant extensive alopecia areata.